CONTACT: Amgen, Thousand Oaks Ashleigh Koss, 805-313-6151 (media) Arvind Sood, 805-447-1060 (investors)(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO) SOURCE Amgen
You think the exchange is overvalued? I don't, and here's why.
Estimates for erenumab annual sales run as high as $2.3 billion.
Corporate America shelled out big bucks for President Trump's inauguration.
The New Brunswick, N.J.-based company noted that its pharma sales dipped due to weakness in the U.S. compared to other markets.